Leveraging endocrine sensitivity in ER-positive DCIS: Neoadjuvant therapy and nonoperative management.
- DOI
- 10.1016/j.breast.2026.104898
- Published
- 2026 Oct
- Container
- Breast (Edinburgh, Scotland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2026.104898,
title = {Leveraging endocrine sensitivity in ER-positive DCIS: Neoadjuvant therapy and nonoperative management.},
author = {Semba R and Childs S and Saw K and Segara D and Mann GB and Shien T and Birrell S and Horimoto Y and Kutomi G and Lim E},
year = {2026},
journal = {Breast (Edinburgh, Scotland)},
doi = {10.1016/j.breast.2026.104898},
url = {https://doi.org/10.1016/j.breast.2026.104898}
}RIS
TY - JOUR TI - Leveraging endocrine sensitivity in ER-positive DCIS: Neoadjuvant therapy and nonoperative management. AU - Semba R AU - Childs S AU - Saw K AU - Segara D AU - Mann GB AU - Shien T AU - Birrell S AU - Horimoto Y AU - Kutomi G AU - Lim E PY - 2026 JO - Breast (Edinburgh, Scotland) DO - 10.1016/j.breast.2026.104898 UR - https://doi.org/10.1016/j.breast.2026.104898 ER -
APA
R, S., S, C., K, S., D, S., GB, M., T, S., S, B., Y, H., G, K., & E, L. (2026). Leveraging endocrine sensitivity in ER-positive DCIS: Neoadjuvant therapy and nonoperative management.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2026.104898
Source records
- pubmed · retrieved 2026-09-25T23:59:10.513Z